Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-28.69 Mil
% of Total Estimate Gain
-55.01%

TCG Crossover Management, LLC's Keros Therapeutics Inc Holding Summary

As of 2025-03-31, TCG Crossover Management, LLC held - shares of Keros Therapeutics Inc(KROS), totaling N/A. This investment constitutes 0% of their stock portfolio, and TCG Crossover Management, LLC now holds 0% of the outstanding Keros Therapeutics Inc(KROS) stock.

The initial trade took place in 2024Q1. And since then TCG Crossover Management, LLC has made 1 purchases of KROS, at an average price of $59.30, for a total of 879,344.00 shares. In addition, there have been 2 sales at an average price of $26.68 for 879,344.00 shares. Based on historical transaction data and KROS's current price of $14.47, TCG Crossover Management, LLC's estimated gain on his KROS holdings is $-28.69 Mil, reflecting a -55.01% gain to date.

TCG Crossover Management, LLC KROS ($14.47) Holding Chart

TCG Crossover Management, LLC KROS ($14.47) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1